Selected research
Industry Growth & Trends
Global Efonidipine Hydrochloride Industry Growth and Trends Forecast to 2032
Market perspective
The global Efonidipine Hydrochloride market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Efonidipine Hydrochloride is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Efonidipine Hydrochloride is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Efonidipine Hydrochloride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Efonidipine Hydrochloride include Topbiochem, Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd, SimSon Pharma Limited, Shionogi & Co., Nissan Chemical Corporation, JOINHUB, Chemicea Limited and BioCrick, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Efonidipine Hydrochloride market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Efonidipine Hydrochloride market size, estimates, and forecasts are presented in terms of sales volume (kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Efonidipine Hydrochloride market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Efonidipine Hydrochloride.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Efonidipine Hydrochloride market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Efonidipine Hydrochloride Market by Company
Topbiochem
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
SimSon Pharma Limited
Shionogi & Co.
Nissan Chemical Corporation
JOINHUB
Chemicea Limited
BioCrick
Efonidipine Hydrochloride Segment by Type
10mg
20mg
Efonidipine Hydrochloride Segment by Application
Renal Function Protection
Elderly Hypertension
Others
Efonidipine Hydrochloride Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Efonidipine Hydrochloride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Efonidipine Hydrochloride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Efonidipine Hydrochloride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Efonidipine Hydrochloride manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Efonidipine Hydrochloride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 10mg
- 20mg
Applications
- Renal Function Protection
- Elderly Hypertension
- Others
Companies covered
- Topbiochem
- Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
- SimSon Pharma Limited
- Shionogi & Co.
- Nissan Chemical Corporation
- JOINHUB
- Chemicea Limited
- BioCrick
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Efonidipine Hydrochloride Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Efonidipine Hydrochloride Sales Estimates and Forecasts (2021-2032)
- 1.3 Efonidipine Hydrochloride Market by Type
- 1.3.1 10mg
- 1.3.2 20mg
- 1.4 Global Efonidipine Hydrochloride Market Size by Type
- 1.4.1 Global Efonidipine Hydrochloride Market Size Overview by Type (2021-2032)
- 1.4.2 Global Efonidipine Hydrochloride Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Efonidipine Hydrochloride Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Efonidipine Hydrochloride Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Efonidipine Hydrochloride Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Efonidipine Hydrochloride Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Efonidipine Hydrochloride Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Efonidipine Hydrochloride Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Efonidipine Hydrochloride Industry Trends
- 2.2 Efonidipine Hydrochloride Industry Drivers
- 2.3 Efonidipine Hydrochloride Industry Opportunities and Challenges
- 2.4 Efonidipine Hydrochloride Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Efonidipine Hydrochloride Revenue (2021-2026)
- 3.2 Global Top Players by Efonidipine Hydrochloride Sales (2021-2026)
- 3.3 Global Top Players by Efonidipine Hydrochloride Price (2021-2026)
- 3.4 Global Efonidipine Hydrochloride Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Efonidipine Hydrochloride Major Company Production Sites & Headquarters
- 3.6 Global Efonidipine Hydrochloride Company, Product Type & Application
- 3.7 Global Efonidipine Hydrochloride Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Efonidipine Hydrochloride Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Efonidipine Hydrochloride Players Market Share by Revenue in 2025
- 3.8.3 2025 Efonidipine Hydrochloride Tier 1, Tier 2, and Tier 3
4 Efonidipine Hydrochloride Regional Status and Outlook
- 4.1 Global Efonidipine Hydrochloride Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Efonidipine Hydrochloride Historic Market Size by Region
- 4.2.1 Global Efonidipine Hydrochloride Sales in Volume by Region (2021-2026)
- 4.2.2 Global Efonidipine Hydrochloride Sales in Value by Region (2021-2026)
- 4.2.3 Global Efonidipine Hydrochloride Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Efonidipine Hydrochloride Forecasted Market Size by Region
- 4.3.1 Global Efonidipine Hydrochloride Sales in Volume by Region (2027-2032)
- 4.3.2 Global Efonidipine Hydrochloride Sales in Value by Region (2027-2032)
- 4.3.3 Global Efonidipine Hydrochloride Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Efonidipine Hydrochloride by Application
- 5.1 Efonidipine Hydrochloride Market by Application
- 5.1.1 Renal Function Protection
- 5.1.2 Elderly Hypertension
- 5.1.3 Others
- 5.2 Global Efonidipine Hydrochloride Market Size by Application
- 5.2.1 Global Efonidipine Hydrochloride Market Size Overview by Application (2021-2032)
- 5.2.2 Global Efonidipine Hydrochloride Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Efonidipine Hydrochloride Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Efonidipine Hydrochloride Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Efonidipine Hydrochloride Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Efonidipine Hydrochloride Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Efonidipine Hydrochloride Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Efonidipine Hydrochloride Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Topbiochem
- 6.1.1 Topbiochem Company Information
- 6.1.2 Topbiochem Business Overview
- 6.1.3 Topbiochem Efonidipine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Topbiochem Efonidipine Hydrochloride Product Portfolio
- 6.1.5 Topbiochem Recent Developments
- 6.2 Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
- 6.2.1 Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd Company Information
- 6.2.2 Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd Business Overview
- 6.2.3 Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd Efonidipine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd Efonidipine Hydrochloride Product Portfolio
- 6.2.5 Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd Recent Developments
- 6.3 SimSon Pharma Limited
- 6.3.1 SimSon Pharma Limited Company Information
- 6.3.2 SimSon Pharma Limited Business Overview
- 6.3.3 SimSon Pharma Limited Efonidipine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 SimSon Pharma Limited Efonidipine Hydrochloride Product Portfolio
- 6.3.5 SimSon Pharma Limited Recent Developments
- 6.4 Shionogi & Co.
- 6.4.1 Shionogi & Co. Company Information
- 6.4.2 Shionogi & Co. Business Overview
- 6.4.3 Shionogi & Co. Efonidipine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Shionogi & Co. Efonidipine Hydrochloride Product Portfolio
- 6.4.5 Shionogi & Co. Recent Developments
- 6.5 Nissan Chemical Corporation
- 6.5.1 Nissan Chemical Corporation Company Information
- 6.5.2 Nissan Chemical Corporation Business Overview
- 6.5.3 Nissan Chemical Corporation Efonidipine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Nissan Chemical Corporation Efonidipine Hydrochloride Product Portfolio
- 6.5.5 Nissan Chemical Corporation Recent Developments
- 6.6 JOINHUB
- 6.6.1 JOINHUB Company Information
- 6.6.2 JOINHUB Business Overview
- 6.6.3 JOINHUB Efonidipine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 JOINHUB Efonidipine Hydrochloride Product Portfolio
- 6.6.5 JOINHUB Recent Developments
- 6.7 Chemicea Limited
- 6.7.1 Chemicea Limited Company Information
- 6.7.2 Chemicea Limited Business Overview
- 6.7.3 Chemicea Limited Efonidipine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Chemicea Limited Efonidipine Hydrochloride Product Portfolio
- 6.7.5 Chemicea Limited Recent Developments
- 6.8 BioCrick
- 6.8.1 BioCrick Company Information
- 6.8.2 BioCrick Business Overview
- 6.8.3 BioCrick Efonidipine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 BioCrick Efonidipine Hydrochloride Product Portfolio
- 6.8.5 BioCrick Recent Developments
7 North America by Country
- 7.1 North America Efonidipine Hydrochloride Sales by Country
- 7.1.1 North America Efonidipine Hydrochloride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Efonidipine Hydrochloride Sales by Country (2021-2026)
- 7.1.3 North America Efonidipine Hydrochloride Sales Forecast by Country (2027-2032)
- 7.2 North America Efonidipine Hydrochloride Market Size by Country
- 7.2.1 North America Efonidipine Hydrochloride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Efonidipine Hydrochloride Market Size by Country (2021-2026)
- 7.2.3 North America Efonidipine Hydrochloride Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Efonidipine Hydrochloride Sales by Country
- 8.1.1 Europe Efonidipine Hydrochloride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Efonidipine Hydrochloride Sales by Country (2021-2026)
- 8.1.3 Europe Efonidipine Hydrochloride Sales Forecast by Country (2027-2032)
- 8.2 Europe Efonidipine Hydrochloride Market Size by Country
- 8.2.1 Europe Efonidipine Hydrochloride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Efonidipine Hydrochloride Market Size by Country (2021-2026)
- 8.2.3 Europe Efonidipine Hydrochloride Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Efonidipine Hydrochloride Sales by Country
- 9.1.1 Asia-Pacific Efonidipine Hydrochloride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Efonidipine Hydrochloride Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Efonidipine Hydrochloride Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Efonidipine Hydrochloride Market Size by Country
- 9.2.1 Asia-Pacific Efonidipine Hydrochloride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Efonidipine Hydrochloride Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Efonidipine Hydrochloride Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Efonidipine Hydrochloride Sales by Country
- 10.1.1 South America Efonidipine Hydrochloride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Efonidipine Hydrochloride Sales by Country (2021-2026)
- 10.1.3 South America Efonidipine Hydrochloride Sales Forecast by Country (2027-2032)
- 10.2 South America Efonidipine Hydrochloride Market Size by Country
- 10.2.1 South America Efonidipine Hydrochloride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Efonidipine Hydrochloride Market Size by Country (2021-2026)
- 10.2.3 South America Efonidipine Hydrochloride Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Efonidipine Hydrochloride Sales by Country
- 11.1.1 Middle East and Africa Efonidipine Hydrochloride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Efonidipine Hydrochloride Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Efonidipine Hydrochloride Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Efonidipine Hydrochloride Market Size by Country
- 11.2.1 Middle East and Africa Efonidipine Hydrochloride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Efonidipine Hydrochloride Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Efonidipine Hydrochloride Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Efonidipine Hydrochloride Value Chain Analysis
- 12.1.1 Efonidipine Hydrochloride Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Efonidipine Hydrochloride Production Mode & Process
- 12.2 Efonidipine Hydrochloride Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Efonidipine Hydrochloride Distributors
- 12.2.3 Efonidipine Hydrochloride Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst